Intellectual Property - March 11, 2026
AnaCardio announces issuance of US patent for AC01
The patent covers the use of AC01 for the treatment of heart failure with reduced ejection fraction (HFrEF).
Intellectual Property - March 11, 2026
Alligator Bioscience strengthens intellectual property protection
The United States Patent and Trademark Office (USPTO) has granted a patent covering Alligator’s bispecific antibody format.
Intellectual Property - February 25, 2026
Salipro Biotech obtains key US patent grant
The new patent secures long term protection for the Salipro platform technologies, extending exclusivity until 2042 and reinforcing the company’s position as a premier partner for drug discovery against challenging drug targets.
Legal Advice article - February 10, 2026
Novo Nordisk sues Hims & Hers over alleged unsafe Wegovy and Ozempic knock‑offs
On 9 February 2026, Novo Nordisk announced it has filed a lawsuit against U.S. telehealth company Hims & Hers, alleging that the firm is offering compounded, non‑FDA‑approved versions of Wegovy and Ozempic that could put patients at risk.
Intellectual Property - January 7, 2026
Mucocort granted Swedish patent
The company has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis). The patent approval strengthens the company’s intellectual property portfolio and represents an important milestone ahead of the international PCT […]
Global report - November 3, 2025
Pfizer files lawsuit against Metsera and Novo Nordisk for breach of merger agreement
Pfizer has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, in the Delaware Court of Chancery.
